Details about the neuroanatomical projections from CA1 to BLAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88627 Field CA1Basolateral nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
The BLA displayed moderate labeling with caudal predominance (Fig. 4B,C). Collator note: increase of labeling of the BLAa from almost no label (Fig. 4A, Swanson Atlas Levels 26-27) to weak-moderate (Fig. 4B, Swanson Atlas Level 28), to quite strong (Fig. 4C, Swanson Atlas Level 29).
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88684 Field CA1Basolateral nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
Within the BLA and BLP, the distribution area of labeled fibers extended more laterally in case R65 (Fig. 7C,D) than did that in case R64 (Fig. 5C,D). Collator note: Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Further details associated to record number 88684:
Position of injection: ventro-caudal
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: caudal
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral